logo
MDRF, U.S. researchers call for precision treatment following discovery of a new subtype of monogenic diabetes

MDRF, U.S. researchers call for precision treatment following discovery of a new subtype of monogenic diabetes

The Hindu08-05-2025
Scientists from the Madras Diabetes Research Foundation (MDRF), Chennai, in collaboration with Washington University School of Medicine in St. Louis, United States, have discovered a previously unrecognised subtype of Maturity-Onset Diabetes of the Young (MODY), and have called for wider access to genetic screening and precision treatment for diabetes patients, particularly in India.
The findings were presented to the media at a conference held at the MDRF here on Thursday.
MODY is a rare, inherited form of diabetes caused by mutations in a single gene, typically appearing in adolescents and young adults. While 13 MODY subtypes have been recognised to date, the newly identified variant challenges long-standing assumptions about the condition, doctors said.
Need for genetic testing in diabetes management
Researchers say the breakthrough not only adds to scientific understanding but also underscores the urgent need to integrate genetic testing into routine diabetes care. This, they noted, could mark a turning point in improving diagnosis, treatment, and long-term disease management for thousands of individuals living with undetected or misclassified forms of monogenic diabetes.
The study, published in the journal — Diabetes —of the American Diabetes Association, identifies Loss of Function (LOF) mutations in the ABCC8 gene (it helps regulate insulin release in the pancreas by controlling a channel that responds to glucose levels, allowing insulin to be released into the bloodstream, when needed), in contrast to the Gain of Function (GOF) mutations previously linked to MODY and neonatal diabetes. The new variant results in early-life hypoglycemia, followed by later-onset diabetes — a progression previously undocumented in MODY cases.
Colin G. Nichols, lead researcher, Washington University School of Medicine, highlighted in the study that the LOF mutation impairs potassium channel function in pancreatic beta cells, disrupting insulin secretion. He said the study marked the first observed switch from congenital hyperinsulinism to diabetes in maturity-onset diabetes of the young context.
Clinical implications and treatment possibilities
Radha Venkatesan, executive scientific officer, head of molecular genomics at MDRF and co-lead author, emphasised the clinical implications of this discovery. 'This variant does not respond to conventional treatments such as sulphonylureas, which are effective in other MODY forms. Understanding the underlying genetic mechanism is key to guiding appropriate therapy,' she said.
V. Mohan, chairman of MDRF, reiterated the importance of incorporating genetic testing into standard diabetes diagnosis. 'Many patients with MODY remain undiagnosed or misclassified as having type 1 or type 2 diabetes. This discovery strengthens the case for precision diagnosis and treatment,' he said.
The findings are based on clinical data and laboratory analysis of Indian patients. Researchers believe that expanding access to genetic testing could lead to earlier detection and more effective care for individuals with monogenic forms of diabetes.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

"Phone Felt Heavy": Astronaut Shubhanshu Shukla On Life After Space
"Phone Felt Heavy": Astronaut Shubhanshu Shukla On Life After Space

NDTV

time2 hours ago

  • NDTV

"Phone Felt Heavy": Astronaut Shubhanshu Shukla On Life After Space

New Delhi: Weeks after returning from the Axiom-4 mission, astronaut Shubhanshu Shukla on Friday shared experiences of readjusting to life on earth like how even a mobile phone felt heavy to hold and he dropped his laptop thinking it would float like in space. Addressing a virtual press conference, Shukla and his Axiom-4 mission colleagues shared the experiences of their 20-day space mission and the 18-day stay at the International Space Station. "After 41 years, a Bharatiya returned to space. But this time, it was not a solitary leap, it was the beginning of India's second orbit. And this time, we are ready, not just to fly but to lead," Shukla said. Shubhanshu Shukla became the second Indian to travel to space after Rakesh Sharma's sojourn as part of the Soviet Russian mission in 1984. Shubhanshu Shukla's Axiom-4 mission blasted off from the Kennedy Space Centre in Florida on June 25 and returned to earth on July 15. The Lucknow-born astronaut said the moment that stood out in the entire space sojourn was when he spoke to the "Prime Minister of Bharat" on June 28 with the tricolour floating behind him. "That moment symbolised India's re-entry into the conversation, not as a spectator but as an equal participant," Shukla said. Sharing his experience of re-adjusting to the gravity on earth, Shukla recalled the moment he asked for a phone to click pictures and how heavy it felt in his hand. "The minute I held the phone, I felt this was heavy. The same phone that we hold all day long felt really heavy to me," Shukla said. Sharing another instance, he said, "I had some work to do on my laptop. I was sitting on my bed and I just closed my laptop and left it to the side of the bed. I dropped my laptop thinking that it would float right next to me. Thankfully, the floor was carpeted so there was no damage done." Shukla said the 20-day mission exceeded his expectations and he learnt a lot that would help India in its Gaganyaan mission. He described his role not just as a spacefarer but as a "messenger showing what's possible". "But the true spark - believing in what is possible in space among young Indians - is what this mission was all about." Shukla said he had done all the homework Prime Minister Narendra Modi had asked him to do on the space station. "I was asked to document everything that we were doing. I can assure you that I have done that very well. I am excited to come back and share all that with our programme. I am confident that all that knowledge is going to prove extremely useful and crucial for our own Gaganyaan mission," he said. "The knowledge that I have gained spans the history of human space missions. I have been fortunate to receive all that," he said. Shubhanshu Shukla said the success of his mission has already started showing results as children back home have started asking how they can become astronauts. "That is also a big success for this mission because one of the primary reasons you do human spaceflight missions is to inspire the younger generation and get them to believe that they can be explorers as well. I think that is already partially achieved. I am extremely happy and pleased with the outcome of this mission," Shukla said. Shukla is expected to return to India mid-August.

Axiom Mission-4 a success for India and Gaganyaan, says astronaut Shubhanshu Shukla
Axiom Mission-4 a success for India and Gaganyaan, says astronaut Shubhanshu Shukla

Time of India

time2 hours ago

  • Time of India

Axiom Mission-4 a success for India and Gaganyaan, says astronaut Shubhanshu Shukla

Academy Empower your mind, elevate your skills India's first astronaut aboard the International Space Station (ISS), Shubhanshu Shukla , on Friday said the success of Axiom Mission-4 (Ax-4) marks India's return to orbit after 41 years, calling it 'India's second orbit.' 'And this time, we are ready not just to fly, but to lead,' he said during a post-mission press briefing, adding that his journey was not just as a spacefarer, but as a messenger of what's now possible for 39-year-old Indian Air Force Group Captain said he feels fit and ready for another space mission. Shukla added that he is confident the knowledge gathered aboard the ISS will prove invaluable to India's upcoming Gaganyaan human spaceflight his time aboard the ISS, Shukla noted that the sight of the Indian flag floating behind him symbolised the country's re-entry into global space conversations 'not as a spectator, but as an equal participant.'Responding to a question from ET, Shukla, who served as the mission's pilot, said the experiments designed by ISRO and Indian researchers were focussed on enabling India's human spaceflight ambitions. 'All these experiments we did on the station also have real-time benefits here on earth, whether it's for understanding degenerative diseases or ensuring food security,' he added that some experiments, such as stem cell research conducted in microgravity, could help decode why muscle atrophy happens and how it might be prevented or delayed, both in space and on earth. India's contribution to the mission included seven microgravity experiments across disciplines such as space medicine, agriculture, and biology, part of the larger set of 60 scientific investigations on four-member Ax-4 crew, comprising astronauts from India, Poland's Sławosz Uznański, Hungary's Tibor Kapu, and NASA veteran Peggy Whitson, will now enter a two-week debriefing phase, during which mission learnings will be reviewed and shared with respective space on the outreach efforts and the true success of the mission, Shukla said the most common question he heard from children was, 'How does one become an astronaut? 'If children across Bharat are already asking these questions, we are halfway there. The rest is just enabling them.'Ax-4 was launched on June 25 and concluded with the return of the crew on July 15.

An edge that endures  Top Medical University
An edge that endures  Top Medical University

India Today

time2 hours ago

  • India Today

An edge that endures Top Medical University

AIIMS continues as the top choice of postgraduate students not only for its cutting-edge facilities, superb faculty and exposure to vast patient inflow, but also for its eager embrace of latest tech like AI No. 1: All India Institute of Medical Sciences (AIIMS), New Delhi The All India Institute of Medical Sciences (AIIMS), was conceived as an institution of excellence that embodied the hopes of a new India, and it has stayed true to that vision. Established in 1956 as an institution of national importance, it was envisioned by then prime minister Jawaharlal Nehru and spearheaded by Union health minister Rajkumari Amrit Kaur. Over the decades, AIIMS Delhi has emerged as India's premier medical institution, renowned for its cutting-edge research, high patient turnover, and specialised treatment facilities. While an MBBS degree from here is much coveted, a PG degree is no less sought after. Postgraduate education at AIIMS Delhi is widely regarded as the pinnacle of medical training in India, offering an unmatched blend of academic excellence, clinical exposure and research opportunities. The institute attracts the country's brightest minds through the highly competitive bi-annual INI-CET exam for admission to the MD/ MS/ DM/ MCh courses. It is taken by 50,000 MBBS and 25,000 dental graduates annually, yet less than one per cent secure a seat. Spread over a large, green campus in South Delhi's Ansari Nagar, the institute offers world-class facilities that promote both professional and personal growth. Students say the highlight of PG education here is the faculty. They guide residents through complex clinical cases, research methodology, biostatistics and critical thinking. With a focus on both teaching and innovation, AIIMS faculty members are not just instructors, they are role models who shape the future of Indian and global healthcare. In 2024 itself, the AIIMS faculty had many achievements to their credit. This year, Dr Neerja Bhatla, head of Gynae Oncology, was honoured with the Padma Shri this year for her pioneering work in cervical cancer prevention. Under Dr DeepakAgrawal's leadership, AIIMS became the first in India to employ Gamma Knife radiosurgery for treating retinoblastoma (cancer in the retina) in children. Dr AshokKumarMahapatra led a groundbreaking multi-hour separation of conjoined craniopagus twins (joined at the head) at AIIMS Delhi, earning national acclaim. Dr PrasunChatterjee was elected Fellow of the Royal College of Physicians of Edinburgh (December 2024) and serves on the WHO Technical Advisory Group for Healthy Ageing. Another big plus point of AIIMS Delhi is its vast and diverse patient inflow from across India, providing PG students with unparalleled exposure to rare and complex cases. This strengthens clinical skills and diagnostic acumen. AIIMS operates one of the busiest trauma centres in Asia, which means students learn how to cope with emergencies and high stress cases from day one itself. There is also the central library, one of the best in Asia, which offers access to thousands of medical journals, e-resources and research databases. Dedicated reading zones and 24/7 digital access are available for PG students. Most importantly, PG students are encouraged to engage in original research, supported by the AIIMS research cell, ethics committees and institutional funding, and aided by the latest medical equipment. Dedicated laboratories for pathology, molecular biology, genetics and radiology support such work. Moreover, AIIMS has collaborations with global institutes like the Harvard Medical School and the World Health Organization, enabling exchange programmes and joint research initiatives. The research results speak volumes. Last year, a team of PG researchers—Trapti Shrivastava, Harshal Chaudhari and Vrijendra Singh—developed a machine learning model for early autism detection. Recently, AIIMS, in collaboration with IIT Delhi, has established a stateoftheart Centre of Excellence for AI in healthcare, proving that it is constantly upgrading, innovating and spearheading excellence in health research. Career prospects after PG at AIIMS Delhi are exceptional. Graduates are sought after for senior residencies, teaching posts and fellowships abroad, and leadership roles in government and private healthcare. Being a PG student at AIIMS Delhi is more than pursuing a degree, it is a transformative experience that equips doctors with the skills and confidence to lead in healthcare. FACULTY COLUMN | The pinnacle is not enough By Dr M. Srinivas, Director, AIIMS Delhi The founding mission of AIIMS Delhi included achieving self-reliance in advanced medical education. Education and research are conducted across nearly 100 disciplines. In 2024 alone, the institute managed 906 extramural research projects funded by national and international organisations and supported 269 intramural research initiatives, with a cumulative grant value exceeding Rs 208 crore. AIIMS Delhi students receive exposure to a diverse array of clinical cases and cutting-edge diagnostic and therapeutic technologies. Responding to evolving healthcare needs, AIIMS has introduced new academic programmes—including a DM in Psychosomatic Medicine under the Department of Psychiatry. The institute places strong emphasis on student wellness. The Department of Psychiatry operates an on-campus wellness centre for students. Recently, an intramural research funding scheme specifically designed to empower postgraduate researchers, was launched. Key developments and initiatives at AIIMS Delhi include the K.L. Wig Centre for Medical Education, Technology & Innovation (CMETi) that hosted multiple capacity-building programmes for faculty and students, and Robotic Surgery Training Facility (MeHNAT), a high-tech training initiative leveraging Medtronic Hugo robotic systems to equip residents and faculty with advanced surgical skills via the SET (Skills, E-learning, Telemedicine) Facility. The SET Facility is the backbone of the National Medical College Network under the Union ministry of health. It supports e-Education and national telehealth efforts by linking medical colleges across India. A wide range of digital learning tools are accessible to students too. Finally, AIIMS Delhi is making notable strides in applying Artificial Intelligence to domains like oncology, medical imaging, ophthalmology and dermatology. It has been designated as a Centre of Excellence for AI/ ML by the Union ministries of health and education. CAMPUS NOTES | The art of medicine Dr Aradhana Sarma, Junior Resident, Dept of Biochemistry Stepping upon the lush expanse of AIIMS Delhi feels transformative, and I consider myself privileged to live and learn within India's most prestigious medical campus. During the week, I find myself immersed in the weekly Journal Club, guest lectures and interactive sessions where faculty and students engage freely in critical discussions. My academic duties include leading case-based discussions, problem-based learning sessions and practicals for MBBS students. These are designed to embed basic biochemical ideas in patient-centred settings, allowing future physicians to relate textbook learning with real-life clinical scenarios. Perhaps the most intriguing portion is thesis work. Our substantial MD projects are driven by complex approaches and continuous trial and error. AIIMS supports this deeply: labs and equipment are accessible 24×7, enabling flexible work schedules. AIIMS can be considered a microcosm of India. Residents bring with them vibrant languages, cuisines, traditions and perspectives. Festivals like Diwali, Onam, Bihu, Baisakhi, Ganesh Chaturthi and Lohri are celebrated together, and language disparities serve as natural bridges for friendships. Of course, life here is intense. AIIMS receives a massive intake of patients, offering unparalleled clinical exposure. Residents use a variety of stress-relieving practices. Some go to the gym or swimming pool, while many, myself included, take late-night walks. For me, a week at AIIMS is an amalgam of intense academics, research opportunities, teaching and moments of community. Here, ambition finds direction and medical education is elevated to an art.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store